Literature DB >> 29283077

Species distribution, sequence types and antimicrobial resistance of Acinetobacter spp. from cystic fibrosis patients.

G A Rocha1, D F Lima1, E R Rodrigues1, R S Leão1, T W Folescu2, M C Firmida3, R W F Cohen2, R M Albano4, E A Marques1.   

Abstract

Acinetobacter spp. are important healthcare pathogens, being closely linked to antibiotic resistance and outbreaks worldwide. Although such species are rarely observed in patients with cystic fibrosis (CF), we describe the characteristics of 53 strains of Acinetobacter spp. isolated from the sputum of 39 Brazilian patients with CF. The species distribution was A. baumannii (n = 29), A. pittii (n = 13), A. nosocomialis (n = 8), A. seifertii (n = 1), A. soli (n = 1) and A. variabilis (n = 1) determined by partial rpoB gene sequencing. Sixteen strains (10 A. baumannii, 3 A. pittii and 3 A. nosocomialis) were multidrug-resistant (MDR) by disk diffusion test (30%) and eight MDR carbapenem-resistant A. baumannii strains harboured the bla OXA-23-like oxacillinase gene. Thirty-three sequence types (STs) were identified by multilocus sequence typing of which eight were novel (A. baumannii: 843, 844, 845, 847, 848; A. pitti: 643; A. nosocomialis: 862 and A. seifertii: 846); six STs (2 A. baumannii, 3 A. pittii and 1 A. nosocomialis) were found in more than one patient. Four strains of A. baumannii were assigned to two common clonal complexes (CCs), namely, CC1 (ST1, ST20 and ST160), and CC79 (ST79). This study underlines the extensive species diversity of Acinetobacter spp. strains in CF lung infections which may present difficulties for therapy due to significant antimicrobial resistance.

Entities:  

Keywords:  zzm321990 Acinetobacter spp.; cystic fibrosis; multidrug resistance; multilocus sequence typing

Mesh:

Substances:

Year:  2017        PMID: 29283077      PMCID: PMC9134553          DOI: 10.1017/S0950268817002849

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   4.434


  24 in total

1.  OXA-23-producing Acinetobacter baumannii: a new hotspot of diversity in Rio de Janeiro?

Authors:  Filipa Grosso; Karyne Rangel Carvalho; Sandra Quinteira; Ana Ramos; Ana Paula D'Alincourt Carvalho-Assef; Marise Dutra Asensi; Luísa Peixe
Journal:  J Antimicrob Chemother       Date:  2010-11-03       Impact factor: 5.790

2.  Dissemination of Acinetobacter nosocomialis clone among critically ill patients and the environment.

Authors:  Valéria Brígido de Carvalho Girão; Natacha Martins; Luciana Camila Cacci; Talita Coelho-Souza; Simone Aranha Nouér; Lee W Riley; Beatriz Meurer Moreira
Journal:  J Clin Microbiol       Date:  2013-05-22       Impact factor: 5.948

3.  OXA-235, a novel class D β-lactamase involved in resistance to carbapenems in Acinetobacter baumannii.

Authors:  Paul G Higgins; Francisco J Pérez-Llarena; Esther Zander; Ana Fernández; Germán Bou; Harald Seifert
Journal:  Antimicrob Agents Chemother       Date:  2013-02-25       Impact factor: 5.191

4.  An outbreak of Acinetobacter baumannii: the importance of cross-transmission.

Authors:  E M D'Agata; V Thayer; W Schaffner
Journal:  Infect Control Hosp Epidemiol       Date:  2000-09       Impact factor: 3.254

5.  eBURST: inferring patterns of evolutionary descent among clusters of related bacterial genotypes from multilocus sequence typing data.

Authors:  Edward J Feil; Bao C Li; David M Aanensen; William P Hanage; Brian G Spratt
Journal:  J Bacteriol       Date:  2004-03       Impact factor: 3.490

6.  Airway microbiota and pathogen abundance in age-stratified cystic fibrosis patients.

Authors:  Michael J Cox; Martin Allgaier; Byron Taylor; Marshall S Baek; Yvonne J Huang; Rebecca A Daly; Ulas Karaoz; Gary L Andersen; Ronald Brown; Kei E Fujimura; Brian Wu; Diem Tran; Jonathan Koff; Mary Ellen Kleinhenz; Dennis Nielson; Eoin L Brodie; Susan V Lynch
Journal:  PLoS One       Date:  2010-06-23       Impact factor: 3.240

Review 7.  Acinetobacter baumannii: emergence of a successful pathogen.

Authors:  Anton Y Peleg; Harald Seifert; David L Paterson
Journal:  Clin Microbiol Rev       Date:  2008-07       Impact factor: 26.132

8.  The changing epidemiology of Acinetobacter spp. producing OXA carbapenemases causing bloodstream infections in Brazil: a BrasNet report.

Authors:  Ana Tereza R Vasconcelos; Afonso L Barth; Alexandre P Zavascki; Ana C Gales; Anna S Levin; Bianca R Lucarevschi; Blenda G Cabral; Danielle M Brasiliense; Flavia Rossi; Guilherme H C Furtado; Irna Carla R S Carneiro; Juliana O da Silva; Julival Ribeiro; Karla V B Lima; Luci Correa; Maria H Britto; Mariama T Silva; Marília L da Conceição; Marina Moreira; Marinês D V Martino; Marise R de Freitas; Maura S Oliveira; Mirian F Dalben; Ricardo D Guzman; Rodrigo Cayô; Rosângela Morais; Sânia A Santos; Willames M B S Martins
Journal:  Diagn Microbiol Infect Dis       Date:  2015-08-12       Impact factor: 2.803

9.  The success of acinetobacter species; genetic, metabolic and virulence attributes.

Authors:  Anton Y Peleg; Anna de Breij; Mark D Adams; Gustavo M Cerqueira; Stefano Mocali; Marco Galardini; Peter H Nibbering; Ashlee M Earl; Doyle V Ward; David L Paterson; Harald Seifert; Lenie Dijkshoorn
Journal:  PLoS One       Date:  2012-10-29       Impact factor: 3.240

Review 10.  Reservoirs of Non-baumannii Acinetobacter Species.

Authors:  Ahmad Al Atrouni; Marie-Laure Joly-Guillou; Monzer Hamze; Marie Kempf
Journal:  Front Microbiol       Date:  2016-02-01       Impact factor: 5.640

View more
  3 in total

Review 1.  An Update on the Novel Genera and Species and Revised Taxonomic Status of Bacterial Organisms Described in 2016 and 2017.

Authors:  Erik Munson; Karen C Carroll
Journal:  J Clin Microbiol       Date:  2019-01-30       Impact factor: 5.948

2.  In vitro and in vivo Virulence Potential of the Emergent Species of the Acinetobacter baumannii (Ab) Group.

Authors:  Clara Cosgaya; Carlos Ratia; Marta Marí-Almirall; Laia Rubio; Paul G Higgins; Harald Seifert; Ignasi Roca; Jordi Vila
Journal:  Front Microbiol       Date:  2019-10-24       Impact factor: 5.640

Review 3.  Management of Multidrug Resistant Infections in Lung Transplant Recipients with Cystic Fibrosis.

Authors:  Jaideep Vazirani; Thomas Crowhurst; C Orla Morrissey; Gregory I Snell
Journal:  Infect Drug Resist       Date:  2021-12-10       Impact factor: 4.003

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.